Vir Biotech Exec Sells $8k in Stock for Tax Withholding
Vir Biotechnology, Inc.
Subscribe to track VIR
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Vir Biotech Exec Sells $8k in Stock for Tax Withholding
Company: Vir Biotechnology, Inc. (VIR) Form: 4 | Filed: 2025-11-04 Significance: Low
Insider: de Verneuil Vanina Title: EVP and General Counsel | Relationship: Officer
Transaction: • Type: Sell (Tax Withholding) • Shares: 1,365 • Price: $5.86 • Value: $8,003 • Owned After: 80,595
Key Insight: This is a routine, non-discretionary "sell-to-cover" transaction to satisfy tax obligations from vested RSUs. It holds minimal trading significance.
Market Context: The transaction represents less than 0.001% of the company's market cap and outstanding shares, indicating no change in insider sentiment.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Vir Biotechnology, Inc. (VIR)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An executive conducted a small, automatic sale of stock to cover tax liabilities associated with vested Restricted Stock Units (RSUs). This is a non-discretionary event and does not signal a change in insider sentiment.
- Market Impact: Neutral. The transaction is too small to have any market impact.
Company Information
| Field | Value |
|---|---|
| Company | Vir Biotechnology, Inc. |
| Ticker Symbol | VIR |
| CIK | 0001706431 |
| Industry | BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) |
Insider Information
| Field | Value |
|---|---|
| Name | de Verneuil Vanina |
| CIK | 0002036234 |
| Title/Position | EVP and General Counsel |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-03 |
| Transaction Code | S (Sale) |
| Security Type | Common Stock |
| Shares Involved | 1,365 |
| Price Per Share | $5.863 |
| Total Value | $8,003 |
| Shares Owned After | 80,595 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $8,003 |
| % of Market Cap | 0.001% |
| Shares Transacted | 1,365 |
| % of Shares Outstanding | 0.001% |
| Post-Transaction Ownership | 80,595 shares (0.058% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The $8,003 transaction is negligible against Vir Biotechnology's market capitalization of $0.83 billion.
- Ownership Concentration: The insider's post-transaction ownership of 0.058% is not a significant stake in the company.
- Transaction Significance: The sale represents an immaterial fraction of both the company's market value and total shares, confirming its low significance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The filing's footnote explicitly states this was an automatic sale to cover tax withholding obligations. Such transactions are pre-planned or automatic and do not reflect an insider's market outlook.
Volume & Sentiment
- Expected Volume Impact: Negligible. The transaction size is too small to affect trading volume.
- Sentiment Indicator: Neutral. This is a routine corporate action, not a discretionary trade.
Additional Context
Special Circumstances
- Footnote F1: The filing confirms this was an "automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.